opc 12759 has been researched along with Systemic Inflammatory Response Syndrome in 1 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimada, S | 1 |
| Inoue, K | 1 |
| Kuramoto, M | 1 |
| Suzuki, S | 1 |
| Yamamoto, K | 1 |
| Ogawa, M | 1 |
1 trial available for opc 12759 and Systemic Inflammatory Response Syndrome
| Article | Year |
|---|---|
Preoperative administration of rebamipide significantly lowers body temperature and circulating interleukin-6 in gastric cancer patients after gastrectomy.
Topics: Aged; Alanine; Chemoprevention; Enzyme Inhibitors; Female; Fever; Gastrectomy; Humans; Interleukin-6 | 2003 |